Reuters logo
BRIEF-Halozyme reports Q2 loss per share $0.23
2017年8月8日 / 晚上8点22分 / 1 个月前

BRIEF-Halozyme reports Q2 loss per share $0.23

Aug 9 (Reuters) - Halozyme Therapeutics Inc-

* Halozyme reports second quarter 2017 results

* Q2 loss per share $0.23

* Q2 revenue $33.8 million versus I/B/E/S view $31.8 million

* Q2 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S

* Sees FY 2017 revenue $115 million to $130 million

* Halozyme Therapeutics Inc sees 2017 net revenue of $115 million to $130 million

* Halozyme Therapeutics Inc sees 2017 operating cash burn of $75 million to $85 million

* Halozyme Therapeutics Inc sees 2017 year-end cash balance of $245 million to $260 million

* FY2017 revenue view $132.1 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below